Soleno

Unfortunately, this is the direction the industry is going. Makes more sense for primary care but not for rare disease w/multiple states.
This is not the direction the industry is going. This is the direction of companies that don't truly understand or care about the needs of their field employees. There are plenty of good companies that will never go in this direction.